A Study to Evaluate the Efficacy and Safety of Multiple Targeted Therapies as Treatments for Participants With Non-Small Cell Lung Cancer (NSCLC)
Clinical trial NCT03178552 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03178552
- Sponsor
- Hoffmann-La Roche
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-22
- Primary completion
- 2026-10-31
- Enrollment
- 1000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.